Clinical Trial Update: Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports on the efficacy and safety of nimodipine to prevent mild cognitive impairment after acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Stroke

Drugs mentioned

• Nimodipine (Nimodipine)

Snippet

Sponsor: Ministry of Science and Technology of the People´s Republic of China | Conditions: Stroke, Mild Cognitive Impairment | Phase 4 | Status: UNKNOWN